Nido Biosciences is translating today’s neuroscience breakthroughs into tomorrow’s treatments for severe neurological diseases.
Nido Biosciences
Neuroscience and Biotech Executives Transition to Investing in Startups
Molecules, Free Full-Text
Role of MUC4–NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
Nido Biosciences
Nido Biosciences
Oral SBMA therapy shows safety and tolerability in Phase 1 trial
Effect of MUC4-NIDO domain deletion on cell motility, i
Javier Diaz-Nido Universidad Autónoma de Madrid - Academia.edu
BioCentury - New VC Bioluminescence believes downturn offers ripe opportunity for platform investing
Portfolio — Dreavent Ecosystem
Jeremy Springhorn : Positions, Relations & Network - MarketScreener
Kennedy's Disease Association
逾一亿美元助力！这家新锐如何改变神经疾病疗法开发方式？ 今日，Nido Biosciences 宣布完成种子轮、A轮和B轮融资，总计数额1.09亿美元。该公司致力于利用对人类遗传
